Renowned molecular diagnostics provider CepheidCPHD recently entered into a non-exclusive distribution agreement with Henry Schein Medical, the Medical business of one of the leading healthcare ...
The Damien Center in Indiana is now using the Cepheid GeneXpert system to detect active hepatitis C infection in an hour, and ...
Managing One of the Largest Enterovirus Testing Populations, Children's Medical Center Dallas Among Leading Institutions to Quickly Adopt Cepheid's SUNNYVALE, Calif ...
SUNNYVALE, Calif. and BIRMINGHAM, Ala., June 27, 2022 /PRNewswire/ -- Cepheid and BioGX today announced a collaboration between the two companies to deliver a PCR test for Monkeypox that will run on ...
Diagnostics are not just breaking out of the lab. Now they're about to be available anywhere the patient is with a new device from Cepheid ($CPHD) that it says is the ...
Cepheid (Nasdaq: CPHD) and FIND today announced that Xpert ® HIV-1 Qual, a qualitative 90-minute molecular HIV test, has achieved CE-IVD status under the European Directive on In Vitro Diagnostic ...
GeneXpert Anthrax tests combine sample preparation with real-time PCR (polymerase chain reaction) amplification and detection for fully automated DNA analysis. The system purifies, concentrates, ...
SUNNYVALE, Calif., Feb. 10, 2016 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced that Warren Kocmond, formerly Executive Vice President and Chief Operating Officer, has been promoted to the ...
Cepheid (Nasdaq: CPHD) today announced the international availability of an update to Xpert® Carba-R, with the addition of two newly emerging carbapenemase genes, OXA-181 and OXA-232. The on-demand, ...
Cepheid, a leading molecular diagnostics company, announced an agreement with Henry Schein Medical, the US Medical business of Henry Schein, Inc., for the distribution of its GeneXpert System and menu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results